Neoadjuvant endocrine therapy, when and why?

Date 02 May 2019
Event ESMO Breast Cancer 2019
Session Early breast cancer: HER2-/HR positive
Topics Clinical Research
Biological Therapy
Breast Cancer
Presenter Cynthia Ma
Authors C.X. Ma
  • -, Washington University, St. Louis/US